Kim Janda - Sep 27, 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Stock symbol
SRNEQ
Transactions as of
Sep 27, 2021
Transactions value $
-$250,456
Form type
4
Date filed
9/28/2021, 05:37 PM
Previous filing
Sep 14, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Options Exercise $63K +35K +1166.67% $1.80* 38K Sep 27, 2021 Direct F1
transaction SRNEQ Common Stock Options Exercise $26.3K +7.36K +19.36% $3.57* 45.4K Sep 27, 2021 Direct F1
transaction SRNEQ Common Stock Sale -$340K -42.4K -93.39% $8.02* 3K Sep 27, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Options Options Exercise $0 -35K -100% $0.00* 0 Sep 27, 2021 Common Stock 35K $1.80 Direct F1, F3
transaction SRNEQ Stock Options Options Exercise $0 -7.36K -21.02% $0.00 27.6K Sep 27, 2021 Common Stock 7.36K $3.57 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.03, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/12 of the original number of shares subject to this option vested and became exercisable on October 15, 2017 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
F4 1/12 of the original number of shares subject to this option vested and became exercisable on December 26, 2018 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.